Abstract
In vitro–generated soft tissue could provide alternate therapies for soft tissue defects. The aim of this study was to evaluate methacrylated gelatin/hyaluronan as scaffolds for soft tissue engineering and their interaction with human adipose–derived stem cells (hASCs). ASCs were incorporated into methacrylated gelatin/hyaluronan hydrogels. The gels were photocrosslinked with a lithium phenyl-2,4,6-trimethylbenzoylphosphinate photoinitiator and analyzed for cell viability and adipogenic differentiation of ASCs over a period of 30 days. Additionally, an angiogenesis assay was performed to assess their angiogenic potential. After 24 h, ASCs showed increased viability on composite hydrogels. These results were consistent over 21 days of culture. By induction of adipogenic differentiation, the mature adipocytes were observed after 7 days of culture, their number significantly increased until day 28 as well as expression of fatty acid binding protein 4 and adiponectin. Our scaffolds are promising as building blocks for adipose tissue engineering and allowed long viability, proliferation, and differentiation of ASCs.
Keywords: Soft tissue defects, adipose-derived stem cells, adipose tissue, methacrylation
Introduction
Tissue defects due to trauma, tumor removal, or diseases are mainly treated with autologous tissue transfer or allogenic tissue. However, there are limited autologous sources for these treatments, and they come at the expense of donor site morbidity or immunogenic reactions of the allogenic transplant. An artificial vascularized soft tissue substitute could offer alternative strategies. Various approaches have been made to create tissue-engineered adipose tissue, and quite a few have been shown suitable for this purpose. The choice of the scaffold material is of utterly importance in tissue engineering, and therefore, researchers have made many advances in the field of biomaterials. Basically, there are synthetic and naturally derived scaffold biomaterials, and they hold different advantages. Some examples of common synthetic biomaterials in adipose tissue engineering are silicones, poly-(ethylene) glycol, and poly-(lactic acid).1–3 The advantage of these materials is that their production is controllable in terms of specific material and degradation properties; furthermore, some of these materials support adipogenesis in vitro and in vivo.1 Likewise, scaffolds made of components generated by biologic systems like collagen, hyaluronan, and fibrinogen show good biocompatibility and support adipogenesis; but there is limited ability to control their production, and as a result, some are not well utilized yet. Nonetheless, naturally derived materials are better absorbed by the human body and cause less immune reaction when compared with synthetic ones. Hyaluronic acid (HA) is a naturally occurring polysaccharide which is ubiquitous in the human body and constitutes an important part of the extracellular matrix (ECM). Among one of its various biological functions, HA has been identified as a key player in human embryonic development. Additionally, it induces increased adipogenesis in vitro and in vivo tissue engineering4–7 and plays a role in angiogenesis and wound healing.8 Gelatin (G) is another naturally derived material consisting of partially degraded collagen—by virtue of being partially degraded it presents with less antigenicity when compared with collagen. G can be used to create a vast number of shapes with little effort. It provides structural stability and contains cell adhesion–enhancing amino acid sequences. It has been shown to increase adipogenesis in vivo.9,10 Both HA and G have traits which seem perfect for soft tissue engineering. Hydrogels are gels with unique characteristics. They contain hydrophilic polymers, which can form porous structures and absorb high amounts of water.11,12 Hydrogels are already used in the clinic, which makes them appealing for biomedical research and tissue engineering.13,14
In addition to materials, cells are another key player in adipose tissue engineering. Adipose-derived stem cells (ASCs) have emerged in the spotlight over the past few years and gained in importance for tissue engineering purposes15,16 because of their fibroblast-like morphology and multipotency, that is, ability to differentiate into all mesenchymal cell types and various other cell types.17–19 Approaches using other heterogeneous human cell populations or mature adipocytes or murine 3T3-L1 preadipocytes have been investigated as well,20–23 which all showed cytocompatibility of their constructs and differentiation of the various cell types. Despite their similarity to bone-marrow stem cells (BMSC), ASCs express different cell surface markers.24 However, there is no consistent consensus on the surface marker of ASCs and no highly specific marker set-up so far, which makes it difficult to characterize them properly.25 Many studies have been done using certain scaffold materials to culture ASCs, but only a few have looked into gelatin and hyaluronan composite hydrogels. Those studies mainly focused only on the material structure, biocompatibility, or cellular interactions for short time periods but nonetheless proved their beneficial properties for tissue engineering and bioprinting and characterized their mechanical properties extensively.6,7,26–28 Despite that sufficient adipose tissue construct have not been proposed so far, and therefore, we combined methacrylated gelatin and methacrylated hyaluronan (HyaMA) to generate three-dimensional (3D) scaffolds in which ASCs could form adipose tissue. The aim of this study was to imbed previous findings and combine them to create sufficient tissue constructs. For this, we focused on the analysis of the viability, proliferation, differentiation, and angiogenic potential of ASCs in the scaffold over longer periods of time.
Methods and materials
Isolation of ASCs and cell culture
HASCs were harvested from patients undergoing elective reconstructive surgery, for example, liposuction, breast reconstruction (deep inferior epigastric perforators (DIEP) flap), or abdominoplasty. Patients were mainly women (>82%) with a mean age of 46.7 years and signed an informed consent. Adipose tissues from surgery were transported and prepared under sterile conditions. The cells were isolated according to an established protocol and cultivated up to passage 5 in the following way. Pads of tissue were manually minced using sterile scalpel and scissors, and residual skin was removed. Minced tissue was washed a few times with sterile Dulbecco’s phosphate–buffered saline (DPBS) (PAN Biotech, Aidenbach, Germany) and then digested with collagenase I (Worthington, Lakewood, USA) in a 1:2.5 fat to collagenase ratio on a shaker for 1 h at 37°C at 220 r/min. Digested tissue was filtered through a 100-µm cell strainer (BD Bioscience, Heidelberg, Germany) and centrifuged at 1500 r/min for 5 min. Supernatant was discarded, and pellet was resuspended in red blood cell lysis buffer and incubated on ice for 8 min. Cold medium was added and filtered through a 70-µm cell strainer (BD Bioscience) and centrifuged at 1400 r/min for 5 min. The pellet was suspended in standard culture medium consisting of 1:1 Dulbecco’s modified Eagle’s medium (DMEM) (PAN Biotech), Ham’s F12 (PAN Biotech) and 10% fetal calf serum (FCS) (GE Healthcare Life Sciences, South Logan, USA), and 1% penicillin/streptomycin (PAN Biotech). Cells were counted using CASY-ONE cell counter (Omni Life Sciences, Bremen, Germany) and then seeded in cell culture flasks (Sarstedt, Nümbrecht, Germany). Medium was changed every 2–3 days. Cells were cultivated till they reached 70%–90% confluence and then passaged or used for experiments. For the in vitro angiogenesis assay, human umbilical vein endothelial cells (HUVECs) were purchased and cultured with endothelial growth medium endothelial cell growth medium 2 (EGM-2) (Lonza, Cologne, Germany). HUVECs were cultured no further than passage 5 for experiments.
Adipogenic differentiation
Differentiation of ASCs to adipocytes was induced by an established protocol.21 A volume of 0.5 mM of 3-isobutyl-1-methylxanthin (AppliChem, Darmstadt, Germany), 200 µM of indomethacin (Biotrend, Cologne, Germany), 1 µM of dexamethasone (Tocris Bioscience, Bristol, UK), and 10 µg/mL of insulin (Sigma-Aldrich, Taufkirchen, Germany) were added to standard culture medium. Adipogenic differentiation was evaluated by Oil-Red O or AdipoRed staining after 3–4 weeks.
Photoinitiators
Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) is a water-soluble photoinitiator (PI). LAP was synthesized as previously described.29 The PI was used to polymerize GelMA and HyaMA solutions to hydrogels with 365-nm light. Eosin and LAP PIs were used in concentrations as previously described.21,30
Cytotoxicity of PIs
Potential cytotoxic effects of the PIs were analyzed with MTT cytotoxicity assay (Sigma-Aldrich). The yellow tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is reduced to purple formazan by intracellular enzymes of viable cells, and the absorbance of the solution can be measured by spectrophotometry. For the cytotox assay, 3T3-L1 murine preadipocytes were cultured on a 96-well plate for 24 h with DMEM + 10% FCS + 1% penicillin/streptomycin at 37°C. The next day, the corresponding concentrations of Eosin Y (2 mg/mL) and LAP (0.5 µg/µL) used for hydrogel cross-linking were added to the culture and incubated for 24 h/48 h. MTT was added according to the manufacturers’ protocol and was incubated with cells for 4 h at 37°C protected from light. Subsequently, the dye solution was removed and cells were lysed with dimethyl sulphoxide (DMSO) (Carl Roth, Karlsruhe, Germany), and glycine buffer was added prior to spectrophotometry reading.
Synthesis of methacrylated gelatin and hyaluronan
Methacrylated gelatin (GelMA) was synthesized according to a procedure previously described by Hoch et al.31 and Van Den Bulcke et al.32 HyaMA was prepared as described by Moller et al.33 Methacrylated gelatin and hyaluronan was obtained by treatment with glycidyl methacrylate (10-fold excess). The reaction was stopped by adding glycine to the reaction mixture. Subsequent dialysis and lyophilization led to methacrylated hydrogel components.
Hydrogel preparation
Two stock solutions of lyophilized methacrylated gelatin were made by solving gelatin in sterile phosphate buffer saline (PBS) to 10% and 20% GelMA stock solutions. A 2% HyaMA stock solution was prepared in the same way. The stock solutions were kept at 4°C in dark place for a maximum of 1 week. For the hydrogel fabrication, the GelMA and HyaMA stocks were warmed to 37°C and 6 µL 0.795 g/mL triethylamin (TEA) (Merck, Darmstadt, Germany) in sterile H2O with pH 7.2, and medium or cell suspension was added and intermixed corresponding to the calculated concentrations and volumes. The cross-linker LAP was added to the mix, and cloning cylinders were filled with 100 µL of the solution. Cross-linking was performed for 5 min under a ultraviolet (UV) light with 365 nm wavelength. GelMA hydrogels of 5% and 10% and a composite hydrogel of 4% GelMA/1% HyaMA (composite) were fabricated with 1 × 106 incorporated ASC/mL gel solution. Additionally, we modified the composite mixture for the angiogenesis assay by adding 1.6-mg fibrinogen (Sigma-Aldrich) and 0.02 units thrombin (Sigma-Aldrich) per mL gel suspension. Due to its four main components, the mixture was called quattroGel.34
Swelling
Hydrogels were weighed immediately after hydrogel gelation (Ws) and placed in a vacuum dryer (Savant Speed Vac). They were dried at 45°C with negative pressure for 24 h. The next day, dried gels were weighed again (Wd), and swelling ratio (Q) was calculated as previously described35–37
Dried hydrogels were placed in distilled water and rehydrated. They were removed from the water at defined time points, excess water was removed, and they were weighed again.
Viability assay
ASCs were seeded on prepared hydrogels (n = 9) in 96-well plates and incubated with AlamarBlue® cell viability assay reagent (Lifetechnologies, Carlsbad, USA) for 24 h at 37°C protected from light. AlamarBlue® reagent is a water-soluble, non-toxic dye that is converted by cells with metabolic activity. The colorimetric change or a fluorescent signal can be measured by fluorometry or spectrophotometry at 562–630 nm. Corresponding hydrogels (n = 3) without cells were used to normalize the absorbance of each group. Viability was measured after 1, 7, 14, and 21 days of culture with Elx 808 microplate reader (BioTek Instruments, Inc., Bad Friedrichshall, Germany), and ASCs seeded on cell culture polystyrene were used as controls. The cell viability was calculated over time. Furthermore, the viability of ASCs on different gels with standard medium (SM) and adipogenic differentiation medium (ADM) was measured.
Microscopy
Live/dead staining of hydrogels
For evaluation of live/dead cell ratio, the hydrogels were cut longitudinally with a scalpel and placed in wells. The halves were carefully washed once with PBS, and the cytoplasma of living cells stained with 5 µg/mL Calcein AM (BD Bioscience) and the free DNA of dead cells with 5 µg/mL propidium iodide (Sigma-Aldrich) for 30 min. Then, staining solution was discarded and PBS added.
Triglyceride/nuclei/cytoplasm staining
Accumulated triglycerides or fatty acids were stained with the fluorescent dye AdipoRed (Lonza). Additionally, nuclei were stained with Hoechst 33342, and cytoplasm of vital cells was stained with fluoresceindiacetate (FDA). Hydrogels were cut and washed as described before and then incubated with 1 µg/mL Hoechst 33342 at room temperature in a dark place for 15 min. After incubation, AdipoRedTM was added according to the manufacturers’ protocol, and FDA of 100 µg/mL was added to the mix. The gels were again incubated in a dark place for 15 min at room temperature. Finally, staining solution was discarded, and the gel washed twice.
The stained hydrogels were placed on microscopy slides and examined with an inverse Olympus X83 microscope (Olympus, Hamburg, Germany).
Histology
Whole constructs were fixed in 4% paraformaldehyde in PBS overnight at 4°C and embedded in optimized cooling temperature medium (Tissue-Tek O.C.T Compound) and frozen in the vapor phase of liquid nitrogen. Cryosections of 10–15 µm were made at −21°C and stained with hematoxylin/eosin.
Image processing and analysis
Microscopic images were taken with an inverse Olympus X83 microscope (Olympus) and the cellSens Software. After exported images of hydrogels were processed using ImageJ (National Institute of Health, Bethesda, USA), to address noise and background in fluorescent images of hydrogels, the background was subtracted and brightness/contrast was fitted.
In vitro angiogenesis
In vitro angiogenesis was analyzed with a tube formation assay. The assay was performed according to manufacturers’ protocol (ibidi, Martinsried, Germany).38 Matrigel (BD Bioscience) was used as a positive control. Hydrogels were placed in triplicates in µ-slides (ibidi, Martinsried, Germany), and HUVECs or HUVEC spheroids were seeded on them and cultured with endothelial growth medium EGM-2 (Lonza) for 20 h. Phase-contrast and fluorescent images of the Calcein AM (BD Biosciences)–stained tubes and sprouts were taken and processed using the Angiogenesis Analyzer plugin for ImageJ (National Institute of Health).
RNA isolation
Total RNA was isolated on Days 0 (control, before differentiation) and 7 using the RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany) according to the manufacturers’ instructions. Before starting RNA isolation, a stainless steel bead (5 mm, Qiagen) was added to a 2-mL tube (containing 1 mL Qiazol), and gels were disrupted for 2 min using a handheld rotor-stator homogenizer (TissueRuptor, Retsch, Germany). RNA was quantified using the NanoDrop ND-1000 instrument (Peqlab Biotechnologies, Wilmington, USA). We used the Experion RNA Analysis Kit (BioRad, Munich, Germany) to check the RNA quality. The Experion-automated electrophoresis system employs LabChip microfluidic technology to automate electrophoresis for RNA analysis and offers determination of total RNA and messenger RNA (mRNA) purity and concentration at nanogram levels. The RNA integrity number (RIN) is a numerical assessment of the integrity of RNA. A RIN over 8 indicates a high quality of RNA. In our test, we observed RIN numbers of 9.7–9.8.
Complementary DNA
Subsequently, RNA was transcribed into complementary DNA (cDNA) using the high-capacity cDNA Reverse Transcription Mix (Applied Biosystems, Life Technologies, Ltd, Paisley, UK) according to the manufacturers’ instructions.
Low-density assay
Gene expression levels of 48 genes associated with fat metabolism were determined using low-density assay (LDA, for according gene list, see Supplementary File). This experiment was carried out with hASCs obtained from three different donors. All cycle threshold (CT) values were normalized to 18 s, and the expression was normalized to undifferentiated cells (day 0, control). Expression levels were calculated using the 2–ΔΔCT method.
Statistics
Data are reported as mean ± standard error of the mean (SEM), and all statistical analyses were performed with GraphPad Prism 6.0.1. Moreover, data were analyzed with student t-test or analysis of variance (ANOVA) if more than two groups were compared. Differences were considered as statistically significant with a p value <0.05.
Results
Methacrylated gelatin and composite methacrylated gelatin and hyaluronan hydrogels of 5% and 10% were fabricated with encapsulated hASCs.
Characterization of hydrogels and cells
The hydrogels were produced in a cylindrical shape (Figure 1(a)) with a porous microstructure Figure 1(c)). A porous microstructure is important for diffusion and nutrient supply within the hydrogels; therefore, we confirmed porosity by analyzing frozen sections of our hydrogels through hematoxylin and eosin staining (Figure 1(c)).
ASCs derived from adipose tissue showed fibroblast-like morphology under standard culture conditions in tissue plastic (Figure 1(b)). Since the hASCs are still an inhomogeneous cell population, we confirmed the adipogenic potential of the cells through stimulation by ADM. HASCs accumulated fatty acid in fat vacuoles within the cells in 3 weeks (Figure 1(d)) and thus showed adipogenic potential.
Hydrogel swelling
We calculated the swelling ratios of the different hydrogels by measuring the masses of vacuum-dried and swollen hydrogel (Figure 1(e)). The swelling ratios indicate water uptake and thus can reflect uptake of nutrient-containing culture medium, which is necessary for viability, proliferation, and differentiation of encapsulated cells.39 Methacrylated gelatin gels showed no concentration-dependent significant differences in swelling ratios at the endpoint (Figure 1(e)). Nonetheless, 5% gelatin hydrogels did show faster swelling during the first 5 min (Figure 1(e)) (p < 0.05). The composite of GelMA and HyaMA had a significantly higher swelling ratio than gelatin hydrogels (p < 0.05), with almost 30-fold increase in weight due to water uptake, whereas gelatin hydrogels only showed a 12- to 16-fold increase in weight by swelling. All hydrogel combinations reached swelling equilibrium after about 20 min at room temperature.
Cytotoxicity
The choice of the PI for cross-linkable hydrogels is important to ensure successful polymerization of hydrogel but should not affect the viability of the cells. Therefore, we tested the cytotoxicity of LAP and Eosin Y by MTT cytotoxicity assay (Figure 1(f)). Viability of 3T3-L1 cells was measured after 24 h of incubation with the amount of PI necessary for gelation, hence Eosin Y 2 mg/mL and LAP 0.5 µg/µL. Data indicate that neither Eosin Y nor LAP have a negative effect on the viability of cells at the employed concentration. Furthermore, viability increased significantly in cells treated with 0.5 µg/µL LAP (p < 0.05) when compared with an untreated control.
Viability
HASCs were seeded on various hydrogels and on polystyrene cell culture plastic as a control. Methacrylated gelatin hydrogels and composite hydrogels of 5% and 10% were fabricated, and ASCs were seeded on top, and either cultured with standard culture medium or ADM and viability was assessed (Figure 2). The viability of cells was calculated over time. On day 1 the control groups showed significantly higher viability than the experiment groups with the exception of the composite hydrogel cultured with ADM (Figure 2(a)). After 21 days of cultivation (Figure 2(b)), only the composite hydrogels supported similar viability to culture plastic. Additionally, ASCs cultured with ADM on composite hydrogels were significantly more viable when compared with control (p < 0.05). Viability over 21 days was for the stimulated ASCs when compared with unstimulated ASCs, with the exception of those cultured on the 10% GelMA, which had almost no viability (Figure 2(c) and (d)). Microscopic analysis of the hydrogel constructs with Calcein AM/propidium iodide (Figure 3) did show good cell survival after 7 days, with a significantly higher ratio of viable/dead cells for composite gels (13.93 ± 1.5) compared to 5% GelMA (6.96 ± 2.03) and 10% GelMA (4.29 ± 0.51) (p < 0.05) (Figure 3(g)).
Adipogenic differentiation
Gene expression
To focus on the material’s effects on cell behavior, we first tested different hydrogel components such as GelMA and GelMA/HyaMA with regard to their effects on differentiation and gene expression changes associated with fat metabolism. At first glance, cells cultured on hydrogels showed similar expression profile of the selected genes when compared with cells cultured in two-dimensional (2D) tissue culture polystyrene (TCP) (Figure 4(a)–(c)), indicating that under all three conditions, the cells increased their fat metabolism due to differentiation induction media. Nevertheless, ASCs matured on GelMA showed a more similar gene expression profile to the 2D culture when compared with differentiated adipocytes in composite gels (GelMA/HyaMA) (Figure 4(d)), which had significantly lower levels of FABP4 compared to 2D culture and GelMa conditions and adiponectin (ADIPOQ) compared to 2D culture conditions (p < 0.05). The other genes of the fat metabolism were equally expressed in all groups.
In summary, preadipocytes can be differentiated in GelMA and GelMA/HyaMA and become mature adipocytes that express adipocyte-specific genes. In fact, GelMA/HyaMA mixtures induced greater alterations of gene expression compared to the 2D cell culturing; but all important genes were expressed, and there was no impact on the phenotypic differentiation during adipogenesis.
Microscopy
Differentiation of ASCs into mature adipocytes was induced with ADM. ASCs encapsulated in hydrogel were cultured with ADM for up to 28 days and analyzed after days 1, 7, 14, 21, and 28. After 7 days of differentiation, a few cells showed lipid accumulation (Figure 5(a)) in AdipoRed staining, and this increased significantly by day 21 (Figure 5(b) and (c)). Cells did not exhibit different phenotypes in the different hydrogel mixtures (data not shown).
In vitro tube formation
An in vitro angiogenesis assay was performed for analysis of endothelial cells—scaffold interactions and for exploring if the hydrogels could be beneficially tailored for other cell types. HUVECs were seeded on our scaffolds and cultured with EGM-2. Matrigel was used as a positive control. After 24 h on Matrigel, HUVECs exposed a tubular network, which could not be found on the other hydrogel scaffolds (Figure 6(a)). Analysis of the network mesh area (Figure 6(b)) showed a significantly larger mesh area on Matrigel when compared with all other groups (p < 0.01), and on a composite hydrogel with fibrinogen and thrombin (quattroGel) when compared with the 10% methacrylated gelatin gel (p < 0.05). Despite no tube formation on our original scaffolds, the addition of fibrinogen and thrombin did enhance HUVEC proliferation (Figure 6(c)) and morphology (Figure 6(a)) when compared with the other hydrogels (p < 0.05).
Discussion
Tissue engineering has been a rising field in the past decades and advances in this area as well as material sciences led to the emergence of the first functional organs and tissues in the recent years. Despite these achievements, a functional adipose tissue has not been successfully engineered so far. Successful tissue engineering requires precise cellular composition of the target tissue as well as vascularization. Given the wide range of synthetic or naturally derived materials available—and their possible combinations—there might be more than one way to achieve successful adipose tissue engineering.1 We believe that nature-derived materials, which contain proteins necessary for angiogenesis and adipogenesis, may be advantageous to this application. We attempted to create an engineered adipose tissue construct by incorporating human ASCs in a composite scaffold of methacrylated gelatin (GelMA) and HyaMA. These cells were then differentiated into an adipogenic lineage. GelMA and HyaMA21,28,31,32,40–43 are commonly studied in tissue engineering, and similar products are already in clinical use (e.g. HA fillers), which is convenient for further research. But despite that several things have to be taken into account.
Scaffold characterization
The right scaffold should mimic the target tissues’ biological and biomechanical properties to ensure cell vitality, proliferation, differentiation, and matrix protein production. This should be the ultimate goal when designing a scaffold. The methacrylation of the two components allowed us to photocrosslink the components under controlled conditions. This is greatly beneficial to cell survival within gels because cross-linking can be performed with constant temperature, pH, and so on, and there is only short exposition to near UV light (365 nm).21 Hydrogels fabricated in this manner have good mechanical stability and swelling characteristics depending on their concentration;32 the latter property is important for the nutrient supply of the cells.44,45 Cross-linking with LAP in our study allowed us to fabricate hydrogels that were stable for at least 4 weeks. By adding cells to the soluble gel components before cross-linking, constructs can be created in various shapes depending on the used mold.
The stiffness of a scaffold has been shown to stimulate adipogenesis,46 and there is strong evidence that longer curing times lead to stiffer hydrogels.47 Previous studies showed similar storage moduli of GelMA hydrogels with mature adipocytes compared to native tissue when measured with 0.05 N.21 Interestingly, LAP as a photoinitiator did not exert any cytotoxic effect on the cells at the employed concentration, but on the contrary, increased cell viability and thus proved to be superior to Eosin Y in this setting. This might be due to shorter curing times (5 vs 20 min) for LAP and to reported toxicity of Eosin Y. The size of constructs is limited by the constraints of diffusion of nutrients through the scaffold. Diffusion through the scaffold requires absorption as well as transport. Water uptake or swelling of a hydrogel can indicate their capability of nutrient absorption and cell infiltration into the gel.48 Our scaffolds showed high swelling capacity, which was greatly enhanced in composites containing hyaluronan. This is reasonable due to the high water-binding capacity of hyaluronan.49 Equilibrium was reached in ~20 min in all groups, in concert with what was previously described in other macroporous hydrogels by Chang et al.35 and Jain et al.50
Our scaffolds granted a continuous supply of nutrients to the cultivated cells as supported by our data showing increased viability in the composite hydrogels when compared with gelatin hydrogels (Figure 2). Furthermore, our scaffolds mimicked the in situ composition of the ECM by comprising a combination of proteins and a glycosaminoglycan (GAG), like HA, which is the most prominent GAG in skin/soft tissue. This biomimetic condition may enhance cellular viability and ensure proliferation and differentiation. Our data support this statement. Nonetheless, hyaluronan does degrade relatively fast (data not shown), which is why these benefits are only present for the first 7–14 days of cultivation. Finally, the degradation of hyaluronan within a gelatin scaffold of higher stability may lead to larger pore size which often has been proposed to be beneficial for cell growth and differentiation.51 Therefore, a photocrosslinkable hydrogel made of naturally derived components such as gelatin and hyaluronan is a promising option for adipose tissue engineering.
Cells and differentiation
Various cell types such as murine cell-line 3T3-L1, mature adipocytes,21 ASCs, or largely unpurified cells derived from stromal vascular fraction (SVF) have been analyzed in a 3D setting for adipose or soft tissue engineering. All these cell types have shown advantages and disadvantages in terms of cultivation, long-term survival, or comparability in previous studies. ASCs were discovered recently and are not yet accurately described. Nonetheless, they became major players in adipose tissue engineering because of their plasticity and accessability. The differences in yield and adipogenic potential of these cells depend on many factors such as donor age, type, or location of fat tissue and could affect the engineered construct and especially the cell differentiation potential.19,52,53 Therefore, these aspects should be considered to ensure comparable and reproducible results. Additionally, the standard isolation protocol54 leads to a heterogeneous cell population called SVF, which contains fibroblasts, endothelial cells, perivascular cells, macrophages, and ASCs. This fraction is often not further characterized, but rather it is cultured, and after proof of differentiation, for example, lipid accumulation, renamed to ASCs. Recent studies used the SVF to engineer a vascularized adipose tissue, which led to promising results.22,55,56 Therefore, we believe that it may not be necessary to further purify this fraction, and we suggest using it directly for a self-assembling approach. ASCs have become a keystone in adipose tissue engineering because they are easily accessible and are able to differentiate into various cell types including adipocytes.19,54
Adipogenesis
Various scaffold materials have been shown to improve adipogenesis in vitro including gelatin,1 which makes it especially promising for adipose tissue engineering.
Even though ASCs differentiate well in a 2D environment under adipogenic conditions, the results in 3D culture depend on many factors.57 Our results showed slight differences in gene expression of cells cultivated in plastic with respect to those cultivated in GelMA or GelMA/HyaMA.
More specifically, we analyzed expression of the most important genes during adipogenesis of ASCs grown in GelMA and in GelMA/HyaMA and compared it to 2D cell culturing (TCP). These genes include Delta-like 1 (DLK1, also known as preadipocyte factor 1 (PREF-1)), peroxisome proliferator–activated receptor gamma (PPAR-γ), members of CCAAT/enhancer-binding proteins (CEBPs), fatty acid binding protein 4 (FABP4), apolipoprotein E (APOE), and ADIPOQ. DLK1 is found in ASCs but is absent in adipocytes. Therefore, DLK1 is used as a marker for preadipocytes. Consequently, down regulation of DLK1 during differentiation coincides with increased C/EBPβ and C/EBPd, which occurs prior to C/EBPα and PPAR-γ induction. CCAAT/enhancer-binding protein β (C/EBPβ) and C/EBPd are induced early during differentiation and activate PPAR-γ and C/EBPα. PPAR-γ, known to be a master regulator of adipogenesis, is necessary and sufficient to promote adipocyte differentiation. Mature adipocytes show expression of FABP4, APOE, and ADIPOQ.
Our results indicated that preadipocytes differentiated on 2D cell culture expressed some of these genes at levels even greater than those of fully differentiated preadipocytes cultivated in hydrogel components (Figure 6). Interestingly, GelMA only slightly altered expression of genes associated with fat metabolism, whereas GelMA/HyaMA mixtures induced greater alterations of gene expression compared with TCP. Nevertheless, gene expression analysis of preadipocytes grown in GelMA/HyaMA revealed no significant differences affecting the differentiation process; all the genes that we considered important were expressed, and we did not observe any impact on phenotypic differentiation. Based on these data, we suggest that both hydrogels could be well used for the establishment of in vitro fatty tissue.
In vitro vascularization
Despite the importance of the previously discussed parameters, the key for a successful tissue-engineered construct is sufficient vascularization, which still poses a major roadblock in tissue engineering.
In vivo vascularization and in vitro vascularization are opposing approaches, and optimally should be synergistic. Most attempts for fully in vitro vascularized constructs remained unsuccessful so far. Nonetheless, the growth of endothelial cells and their formation can indicate the feasibility of scaffolds for in vitro vascularization. We used a common in vitro tube formation assay to analyze the growth of HUVECs. The cells remained vital on all scaffolds; however, the GelMA and GelMA/HyaMa composites did not promote tube formation. However, addition of fibrinogen and thrombin (quattroGel) enhanced endothelial proliferation and vascular morphogenesis, especially in presence of vascular endothelial growth factor (VEGF).58,59 Co-cultures of ASCs and endothelial cells in quattroGel may show good results because ASCs secrete angiogenetic factors,60–62 which could increase in vitro vascularization. Thus, these hydrogels can work as building blocks in adipose tissue engineering, which can be altered with a variety of proteins to address the needs of different approaches.
Conclusion
We could produce stable, yet cytocompatible, 3D scaffolds with methacrylated gelatin and hyaluronan, which granted viability and differentiation to encapsulated ASCs for longer periods. This stability allowed the cells to survive over a period of 3–4 weeks and enabled the targeted differentiation into adipogenic lineage within the matrix as well. Combined GelMA/HyaMA hydrogels show an advantage in adipogenic differentiation and viability compared to GelMA hydrogels. With additional ECM/protein components, these scaffolds could be tailored sufficiently for soft tissue engineering. Nonetheless is a sufficient vascularization still problematic for these hydrogels and needs further research especially in vivo studies using appropriate models.
Supplementary Material
Acknowledgments
The authors thank Stephanie Abraham and Andrea Rittig for excellent technical assistance.
Footnotes
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the 7th Framework Program of the European Commission as part of the research consortium ArtiVasc 3D (project ref.: 263416).
References
- 1. Choi JH, Gimble JM, Lee K, et al. Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev 2010; 16(4): 413–426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Flynn L, Woodhouse KA. Adipose tissue engineering with cells in engineered matrices. Organogenesis 2008; 4(4): 228–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kral JG, Crandall DL. Development of a human adipocyte synthetic polymer scaffold. Plast Reconstr Surg 1999; 104(6): 1732–1738. [DOI] [PubMed] [Google Scholar]
- 4. Flynn LE, Prestwich GD, Semple JL, et al. Proliferation and differentiation of adipose-derived stem cells on naturally derived scaffolds. Biomaterials 2008; 29(12): 1862–1871. [DOI] [PubMed] [Google Scholar]
- 5. Halbleib M, Skurk T, de Luca C, et al. Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds. Biomaterials 2003; 24(18): 3125–3132. [DOI] [PubMed] [Google Scholar]
- 6. Hemmrich K, Van de Sijpe K, Rhodes NP, et al. Autologous in vivo adipose tissue engineering in hyaluronan-based gels–a pilot study. J Surg Res 2008; 144(1): 82–88. [DOI] [PubMed] [Google Scholar]
- 7. Korurer E, Kenar H, Doger E, et al. Production of a composite hyaluronic acid/gelatin blood plasma gel for hydrogel-based adipose tissue engineering applications. J Biomed Mater Res A 2014; 102(7): 2220–2229. [DOI] [PubMed] [Google Scholar]
- 8. Frenkel JS. The role of hyaluronan in wound healing. Int Wound J 2014; 11(2): 159–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kimura Y, Ozeki M, Inamoto T, et al. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 2003; 24(14): 2513–2521. [DOI] [PubMed] [Google Scholar]
- 10. Lin SD, Wang KH, Kao AP. Engineered adipose tissue of predefined shape and dimensions from human adipose-derived mesenchymal stem cells. Tissue Eng Part A 2008; 14(5): 571–581. [DOI] [PubMed] [Google Scholar]
- 11. Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res 2015; 6(2): 105–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ullah F, Othman MB, Javed F, et al. Classification, processing and application of hydrogels: a review. Mater Sci Eng C Mater Biol Appl 2015; 57: 414–433. [DOI] [PubMed] [Google Scholar]
- 13. Li J, Feng X, Liu B, et al. Polymer materials for prevention of postoperative adhesion. Acta Biomater 2017; 61: 21–40. [DOI] [PubMed] [Google Scholar]
- 14. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2015; 92(5): 971–977. [DOI] [PubMed] [Google Scholar]
- 15. Sterodimas A, de Faria J, Nicaretta B, et al. Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg 2010; 63(11): 1886–1892. [DOI] [PubMed] [Google Scholar]
- 16. Tremp M, Salemi S, Largo R, et al. Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction. World J Urol 2014; 32(5): 1241–1248. [DOI] [PubMed] [Google Scholar]
- 17. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003; 5(5): 362–369. [DOI] [PubMed] [Google Scholar]
- 18. Locke M, Windsor J, Dunbar PR. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 2009; 79(4): 235–244. [DOI] [PubMed] [Google Scholar]
- 19. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal cells–basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25(4): 818–827. [DOI] [PubMed] [Google Scholar]
- 20. Cheng NC, Chen SY, Li JR, et al. Short-term spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis. Stem Cells Transl Med 2013; 2(8): 584–594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Huber B, Borchers K, Tovar GE, et al. Methacrylated gelatin and mature adipocytes are promising components for adipose tissue engineering. J Biomater Appl 2016; 30(6): 699–710. [DOI] [PubMed] [Google Scholar]
- 22. Wittmann K, Dietl S, Ludwig N, et al. Engineering vascularized adipose tissue using the stromal-vascular fraction and fibrin hydrogels. Tissue Eng Part A 2015; 21(7–8): 1343–1353. [DOI] [PubMed] [Google Scholar]
- 23. Thangavel P, Ramachandran B, Muthuvijayan V. Fabrication of chitosan/gallic acid 3D microporous scaffold for tissue engineering applications. J Biomed Mater Res B Appl Biomater 2016; 104(4): 750–760. [DOI] [PubMed] [Google Scholar]
- 24. Mizuno H, Tobita M, Uysal AC. Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012; 30(5): 804–810. [DOI] [PubMed] [Google Scholar]
- 25. Ong WK, Tan CS, Chan KL, et al. Identification of specific cell-surface markers of adipose-derived stem cells from subcutaneous and visceral fat depots. Stem Cell Reports 2014; 2(2): 171–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Camci-Unal G, Nichol JW, Bae H, et al. Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells. J Tissue Eng Regen Med 2013; 7(5): 337–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Nichol JW, Koshy ST, Bae H, et al. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 2010; 31(21): 5536–5544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Skardal A, Zhang J, McCoard L, et al. Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng Part A 2010; 16(8): 2675–2685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Fairbanks BD, Schwartz MP, Bowman CN, et al. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009; 30(35): 6702–6707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bahney CS, Lujan TJ, Hsu CW, et al. Visible light photoinitiation of mesenchymal stem cell-laden bioresponsive hydrogels. Eur Cell Mater 2011; 22: 43–55; discussion 55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Hoch E, Schuh C, Hirth T, et al. Stiff gelatin hydrogels can be photo-chemically synthesized from low viscous gelatin solutions using molecularly functionalized gelatin with a high degree of methacrylation. J Mater Sci Mater Med 2012; 23(11): 2607–2617. [DOI] [PubMed] [Google Scholar]
- 32. Van Den Bulcke AI, Bogdanov B, De Rooze N, et al. Structural and rheological properties of methacrylamide modified gelatin hydrogels. Biomacromolecules 2000; 1(1): 31–38. [DOI] [PubMed] [Google Scholar]
- 33. Moeller S, Weisser J, Bischoff S, et al. Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction. Biomol Eng 2007; 24(5): 496–504. [DOI] [PubMed] [Google Scholar]
- 34. Aberle T, Franke K, Rist E, et al. Cell-type specific four-component hydrogel. PLoS ONE 2014; 9(1): e86740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Chang KH, Liao HT, Chen JP. Preparation and characterization of gelatin/hyaluronic acid cryogels for adipose tissue engineering: in vitro and in vivo studies. Acta Biomater 2013; 9(11): 9012–9026. [DOI] [PubMed] [Google Scholar]
- 36. Khare AR, Peppas NA. Swelling/deswelling of anionic copolymer gels. Biomaterials 1995; 16(7): 559–567. [DOI] [PubMed] [Google Scholar]
- 37. Luong PT, Browning MB, Bixler RS, et al. Drying and storage effects on poly(ethylene glycol) hydrogel mechanical properties and bioactivity. J Biomed Mater Res A 2014; 102(9): 3066–3076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Khoo CP, Micklem K, Watt SM. A comparison of methods for quantifying angiogenesis in the Matrigel assay in vitro. Tissue Eng Part C Methods 2011; 17(9): 895–906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Singh D, Tripathi A, Zo S, et al. Synthesis of composite gelatin-hyaluronic acid-alginate porous scaffold and evaluation for in vitro stem cell growth and in vivo tissue integration. Colloids Surf B Biointerfaces 2014; 116: 502–509. [DOI] [PubMed] [Google Scholar]
- 40. Billiet T, Gevaert E, De Schryver T, et al. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability. Biomaterials 2014; 35(1): 49–62. [DOI] [PubMed] [Google Scholar]
- 41. Moller L, Krause A, Dahlmann J, et al. Preparation and evaluation of hydrogel-composites from methacrylated hyaluronic acid, alginate, and gelatin for tissue engineering. Int J Artif Organs 2011; 34(2): 93–102. [DOI] [PubMed] [Google Scholar]
- 42. Ovsianikov A, Deiwick A, Van Vlierberghe S, et al. Laser fabrication of three-dimensional CAD scaffolds from photosensitive gelatin for applications in tissue engineering. Biomacromolecules 2011; 12(4): 851–858. [DOI] [PubMed] [Google Scholar]
- 43. Jha AK, Xu X, Duncan RL, et al. Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networks. Biomaterials 2011; 32(10): 2466–2478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Brandl FP, Seitz AK, Tessmar JK, et al. Enzymatically degradable poly(ethylene glycol) based hydrogels for adipose tissue engineering. Biomaterials 2010; 31(14): 3957–3966. [DOI] [PubMed] [Google Scholar]
- 45. Nicodemus GD, Bryant SJ. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 2008; 14(2): 149–165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Young DA, Choi YS, Engler AJ, et al. Stimulation of adipogenesis of adult adipose-derived stem cells using substrates that mimic the stiffness of adipose tissue. Biomaterials 2013; 34(34): 8581–8588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Lin RZ, Chen YC, Moreno-Luna R, et al. Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel. Biomaterials 2013; 34(28): 6785–6796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Jayakumar R, Ramachandran R, Sudheesh Kumar PT, et al. Fabrication of chitin-chitosan/nano ZrO(2) composite scaffolds for tissue engineering applications. Int J Biol Macromol 2011; 49(3): 274–280. [DOI] [PubMed] [Google Scholar]
- 49. Lin YC, Tan FJ, Marra KG, et al. Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications. Acta Biomater 2009; 5(7): 2591–2600. [DOI] [PubMed] [Google Scholar]
- 50. Jain E, Srivastava A, Kumar A. Macroporous interpenetrating cryogel network of poly(acrylonitrile) and gelatin for biomedical applications. J Mater Sci Mater Med 2009; 20(Suppl. 1): S173–S179. [DOI] [PubMed] [Google Scholar]
- 51. Von Heimburg D, Zachariah S, Heschel I, et al. Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and in vivo. Biomaterials 2001; 22(5): 429–438. [DOI] [PubMed] [Google Scholar]
- 52. Gimble JM, Bunnell BA, Chiu ES, et al. Concise review: adipose-derived stromal vascular fraction cells and stem cells: let’s not get lost in translation. Stem Cells 2011; 29(5): 749–754. [DOI] [PubMed] [Google Scholar]
- 53. Yang HJ, Kim KJ, Kim MK, et al. The stem cell potential and multipotency of human adipose tissue-derived stem cells vary by cell donor and are different from those of other types of stem cells. Cells Tissues Organs 2014; 199(5–6): 373–383. [DOI] [PubMed] [Google Scholar]
- 54. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211–228. [DOI] [PubMed] [Google Scholar]
- 55. Klar AS, Guven S, Biedermann T, et al. Tissue-engineered dermo-epidermal skin grafts prevascularized with adipose-derived cells. Biomaterials 2014; 35(19): 5065–5078. [DOI] [PubMed] [Google Scholar]
- 56. Lin SD, Huang SH, Lin YN, et al. Engineering adipose tissue from uncultured human adipose stromal vascular fraction on collagen matrix and gelatin sponge scaffolds. Tissue Eng Part A 2011; 17(11–12): 1489–1498. [DOI] [PubMed] [Google Scholar]
- 57. Stacey DH, Hanson SE, Lahvis G, et al. In vitro adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition. Tissue Eng Part A 2009; 15(11): 3389–3399. [DOI] [PubMed] [Google Scholar]
- 58. Ehrbar M, Metters A, Zammaretti P, et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 2005; 101(1–3): 93–109. [DOI] [PubMed] [Google Scholar]
- 59. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96(12): 3772–3778. [PubMed] [Google Scholar]
- 60. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100(9): 1249–1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109(10): 1292–1298. [DOI] [PubMed] [Google Scholar]
- 62. Rubina K, Kalinina N, Efimenko A, et al. Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng Part A 2009; 15(8): 2039–2050. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.